title: [Human papillomavirus infection and adolescence].
abstract: Infection with human papillomavirus has increased dramatically in recent years. The highest prevalence rates are among adolescents and young women, reflecting changes in sexual behavior associated with biological factors in adolescent development. Adolescents who begin sexual activity early are at greater risk of precursor lesions and cervical cancer. There are adolescents with special circumstances, where no early decision should be delayed cervical cytology and in whom it is important to initiate consultations and periodic reviews with a preventive approach. Cervical cancer can be avoided when the diagnosis and treatment of precursor lesions is early. Despite efforts at sex education based on "safe sex" with the correct use of condoms has not been able to reduce the incidence of infections with human papillomavirus in adolescents. While better than nothing, condom use is not 100% reliable. Studies show that consistent and correct use provides protection against the human papillomavirus only 70%. In Mexico, reported an overall ratio of actual use of condoms from 24.6%. It is clear that the physician who provides care for adolescents plays a fundamental role in sex education. The key to future prevention of cervical cancer and its precursor lesions could be the vaccination.
authors.affiliation: Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, México DF.
authors.forename: Selene
authors.initials: S
authors.lastname: Sam Soto
authors.forename: Alejandro Ortiz
authors.initials: AO
authors.lastname: de la Peña y Carranza
authors.forename: Josefina Lira
authors.initials: JL
authors.lastname: Plascencia
mesh_terms: D000293:Adolescent; D000294:Adolescent Behavior; D017668:Age of Onset; D052685:Alphapapillomavirus; D002986:Clinical Trials as Topic; D017280:Condoms / Q000706:statistics & numerical data; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008297:Male; D008800:Mexico / Q000453:epidemiology; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission / Q000821:virology; D053918:Papillomavirus Vaccines; D015995:Prevalence; D012736:Sex Education; D012725:Sexual Behavior; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000517:prevention & control; D014611:Vaccination
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18